Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axonex AI Group Limited - Class A Ordinary Shares (NQ:AXNX)

0.6196 -0.0904 (-12.73%)
Delayed Quote Updated: 11:13 AM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Axonex AI Group Limited - Class A Ordinary Shares

< Previous 1 2 3 Next >
News headline image
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
From RxSight, Inc.
Via GlobeNewswire
News headline image
Axonics Reports Third Quarter 2024 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Reports Second Quarter 2024 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Reports First Quarter 2024 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
News headline image
Axonics Stockholders Approve Merger Agreement with Boston Scientific
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Responds to ITC Action by Medtronic
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
From Axonics, Inc.
Via Business Wire
News headline image
Axonics to Present at the J.P. Morgan Healthcare Conference
From Axonics, Inc.
Via Business Wire
News headline image
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
From NeuroQure
Via GlobeNewswire
News headline image
Axonics to Participate in November Investor Conferences
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Reports Third Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
Axonics to Report Third Quarter 2023 Financial Results on October 30
From Axonics, Inc.
Via Business Wire
News headline image
Axonics to Participate in September Investor Conferences
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Announces CFO Retirement and Appoints Successor
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Reports Second Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
Axonics to Report Second Quarter 2023 Financial Results on July 27
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Reports First Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
Axonics to Participate in Upcoming Investor Conferences
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
From Axonics, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.